Presenting at COSA 2025: Improving Safety Around Denosumab and Intravenous Iron
In November 2025, the View Health – chemo@home team presented at the Clinical Oncological Society of Australia (COSA) Annual Scientific Meeting in Adelaide. The poster, Severe hypophosphataemia following denosumab and intravenous iron infusion, shared a real-world case highlighting the risk of significant electrolyte disturbances when denosumab and intravenous iron are administered too closely together. The […]






